Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world registry study of Compound Duzhong Jiangu Granules for knee osteoarthritis
ChiCTR2600126072Phase 4Recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- Jun 2026
- Countries
- 1
01
Overview
Phase 4, open-label trial of Compound Duzhong Jiangu Granules in knee osteoarthritis (OA) (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoint: Visual Analogue Scale for Pain (VAS pain score). Started Jun 2026; status: recruiting.
02
Drugs
Compound Duzhong Jiangu Granules
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2600126072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126072.